Fat Necrosis of Breast
Fat necrosis is damage to the fatty tissue of the breast, usually following injury, surgery, or radiotherapy, in which the affected fat dies and the body responds with inflammation and scarring. It is entirely benign. Its importance lies almost entirely in how convincingly it can imitate breast cancer—it can produce a hard, irregular, fixed lump with skin dimpling, and on mammography it can show the spiculated mass and irregular calcification that are the classic features of malignancy. This resemblance means fat necrosis is one of the more common reasons for a biopsy that proves benign, and a clear history of trauma or surgery is helpful but never sufficient on its own to avoid assessment.
What is it?
A substantial part of the breast is fat, particularly after menopause, when glandular tissue regresses and is replaced by it. Fat necrosis means that some of this fatty tissue has died.
The process begins when the blood supply to an area of fat is disrupted—by a blow, by surgery dividing small vessels, by radiotherapy damaging them, or by any insult that interrupts perfusion. The fat cells die and release their contents, including free fatty acids. These are irritant, and the body mounts an inflammatory response to clear them.
What follows is a sequence that unfolds over months and explains everything about how fat necrosis presents.
In the earliest stage, there is inflammation. The area is swollen, often tender, and may be warm and bruised. Imaging at this point shows an ill-defined area that can look distinctly abnormal.
Over subsequent weeks and months, the body walls off the damaged area. Inflammatory cells accumulate, the liquefied fat may become enclosed in a thin fibrous capsule forming what is called an oil cyst, and scar tissue develops around the periphery. This is the stage at which the lesion can feel hardest and look most suspicious, because scarring pulls on surrounding tissue, producing a firm, irregular, fixed mass with skin dimpling—precisely the features associated with cancer.
Over a longer period, often a year or more, the lesion typically shrinks. Calcium is deposited in the capsule, producing a characteristic rim of calcification. Mature lesions frequently become confidently recognisable on imaging, and many resolve entirely.
This evolution is why the appearance of fat necrosis depends so heavily on timing, and why a lesion that looked alarming six months ago may look obviously benign now.
The causes are those that damage fat.
Surgery is now the most common. Breast-conserving cancer surgery, reduction mammoplasty, oncoplastic procedures, reconstruction using tissue flaps, and biopsy all disturb fatty tissue. Flap-based reconstruction is particularly associated, since a transplanted segment of fat relies on a newly connected blood supply and areas at the periphery may not survive.
Fat grafting, in which fat is harvested and injected into the breast for reconstruction or augmentation, produces fat necrosis in a meaningful proportion of cases, since injected fat must establish its own blood supply.
Radiotherapy damages small blood vessels and causes fat necrosis within the treated field, sometimes appearing months or years afterwards. This is a particularly important scenario because it arises in women previously treated for breast cancer, in whom any new lump raises the question of recurrence.
Trauma accounts for a substantial share. A seatbelt injury in a road accident is a classic cause. A blow during sport, a fall, or pressure from a tight garment can all be responsible. Notably, a remembered injury is present in only about half of cases—the trauma may have been minor and forgotten, so the absence of a recalled event does not argue against the diagnosis.
Anticoagulation increases the likelihood that minor trauma causes bleeding and subsequent fat necrosis.
Infection, duct ectasia, and inflammatory conditions can also produce localised fat damage.
The symptoms vary considerably, and this variability is itself characteristic.
A lump is the usual presentation. It may be soft or rock hard, smooth or irregular, freely mobile or fixed to surrounding tissue. The hard, irregular, fixed variety is the one that causes concern, and understandably so.
Skin changes frequently accompany it—dimpling, puckering, tethering, thickening, or redness. Where fat necrosis follows recent trauma there may be visible bruising. These skin features arise because the scarring involved in healing pulls on the fibrous bands that run between the breast tissue and the skin, exactly as cancer does.
Nipple retraction can occur where the lesion lies close behind the nipple.
Pain and tenderness are common early and usually settle over months.
Where an oil cyst forms, it is felt as a smooth, round, mobile lump, which is reassuringly benign in character.
Many cases produce no symptoms and are found on imaging.
The reason fat necrosis matters clinically is its capacity to imitate cancer, and this deserves to be stated directly rather than softened. A firm, irregular, fixed lump with overlying skin dimpling, in a woman over 50, is a presentation that correctly prompts urgent assessment for cancer. Fat necrosis produces exactly this. On mammography it can produce a spiculated mass—a lesion with radiating lines extending from it—which is the classic appearance of invasive cancer. It can produce irregular clustered calcification resembling that of ductal carcinoma in situ. On ultrasound it can appear as an irregular, shadowing, solid-looking mass.
This is why a history of trauma or surgery, while useful, cannot by itself substitute for assessment. Cancer can develop at a site where someone happens to have been injured, and attributing a suspicious lump to a remembered blow is a recognised route to delayed diagnosis. The history raises the probability of fat necrosis; it does not establish it.
Diagnosis combines history, imaging, and in many cases biopsy.
The history matters considerably: previous surgery at that site, radiotherapy, injury, anticoagulation, and the time course of the lump. Fat necrosis typically appears weeks to months after the causative event and tends to improve over time, whereas cancer tends to progress.
Mammography is central, and its findings depend on the stage. Early lesions may show an ill-defined or spiculated mass indistinguishable from cancer. Mature lesions show the appearance that allows confident diagnosis: a radiolucent, fat-containing mass with a thin capsule, often with curvilinear calcification around the rim, described as eggshell calcification. The presence of fat within the lesion is the key feature, since cancer does not contain fat. Where this appearance is present, no biopsy is needed.
Ultrasound findings are highly variable, ranging from a simple anechoic cyst, through a cyst with internal echoes or fat-fluid levels, to a solid-appearing irregular mass with shadowing that cannot be distinguished from cancer.
MRI is less helpful than might be expected. Fat necrosis can enhance after contrast and can mimic malignancy, and while fat-suppression sequences demonstrating fat within a lesion are useful, MRI is not reliably diagnostic and may complicate rather than clarify.
Comparison with previous imaging is one of the most valuable steps available. A lesion appearing at the site of previous surgery, evolving in the expected way, or shrinking on serial imaging supports the diagnosis strongly.
Biopsy is performed where appearances are not characteristic, and this is the commonest situation outside mature classical lesions. Core needle biopsy provides the diagnosis, showing the characteristic histological features. An important caveat applies: where biopsy shows fat necrosis but imaging appearances remain suspicious, the result is treated as discordant and further sampling or excision follows, since a needle may have sampled fat necrosis adjacent to a cancer rather than the lesion itself.
A specific scenario deserves attention. In a woman previously treated for breast cancer with surgery and radiotherapy, a new lump at the treatment site raises the question of recurrence. Fat necrosis is a common benign explanation in this setting, but it cannot be assumed, and biopsy is frequently required. Comparison with previous imaging and the pattern of change over time carry particular weight here.
Important to Know
The essential message has two parts that belong together: fat necrosis is entirely benign and requires no treatment, and establishing that diagnosis frequently requires biopsy because it imitates cancer so convincingly. Care is managed by breast services using the standard triple assessment approach.
Many women find it frustrating to undergo imaging and a biopsy for something that turns out to be the consequence of a forgotten knock or an operation they had months ago. The reason is worth understanding rather than simply accepted: the features that make a lump worrying—hardness, irregularity, fixation, skin dimpling, spiculation on mammography—are produced by fat necrosis just as they are by cancer, and no clinician can reliably distinguish them without tissue in many cases. A biopsy that proves benign is a successful outcome rather than an unnecessary one.
Once the diagnosis is confirmed, nothing further is needed. Fat necrosis does not become cancer, does not increase the risk of developing breast cancer, and does not require surveillance beyond routine screening.
The natural course is favourable. Most lesions soften and shrink over months to a couple of years, and many disappear entirely. Pain settles. The lump becoming smaller and softer over time is reassuring and is the expected pattern. Simple analgesia and a supportive bra manage symptoms in the meantime.
An oil cyst that is large or uncomfortable can be aspirated, which relieves the symptom immediately, though cysts may refill.
Surgery is generally avoided. Excising fat necrosis is rarely necessary, and there is a particular logic to avoiding it: the operation disturbs fatty tissue and can itself produce further fat necrosis, so surgery risks recreating the problem it was intended to solve. It is reserved for lesions causing persistent significant pain, lesions that continue to enlarge, and situations where diagnostic uncertainty has not been resolved by imaging and biopsy.
Several situations deserve particular attention.
In women who have had breast cancer treated with surgery and radiotherapy, a new lump in the treated breast is assessed thoroughly rather than attributed to scarring. Fat necrosis is common in this setting and is a frequent explanation, but recurrence must be excluded, and this usually means biopsy. A woman in this position should expect a careful assessment and should not interpret it as a sign that recurrence is suspected.
After fat grafting for reconstruction or augmentation, fat necrosis is a recognised and relatively common outcome. Women undergoing this procedure should be told to expect that firm areas may develop, that these are usually benign, and that assessment may nonetheless be needed. The resulting lumps and calcifications can complicate subsequent breast imaging, and the surgical history should always be disclosed when attending for a mammogram.
After flap reconstruction, areas of fat necrosis within the flap are common, particularly at the edges where blood supply is most marginal. These are usually identified early and managed expectantly.
After breast reduction, firm areas within the breast are frequent and are generally fat necrosis. The same principle applies: common, benign, but assessed if new or changing.
The calcifications that develop in mature fat necrosis are worth understanding, since they persist indefinitely and appear on all subsequent mammograms. The characteristic eggshell or curvilinear rim calcification around an oil cyst is confidently benign and is recognised as such by radiologists, so it does not typically cause recall. Less typical calcification associated with fat necrosis can be harder to categorise and may prompt further assessment.
Breast awareness remains important. A woman with known fat necrosis should continue to notice changes and report anything new, rather than attributing every subsequent finding to it. In particular, a lump that enlarges rather than shrinks, or a new lump in a different area, warrants assessment on its own merits. The expected course is improvement, so deviation from that course is informative.
Screening attendance continues unchanged, with the surgical and trauma history mentioned at each visit so that the appearances can be interpreted correctly.
Care is managed by breast services, with imaging, clinical findings, and pathology interpreted together, and comparison with previous imaging carrying particular weight in this condition.
Patient education plays an important role. Understanding that fat necrosis is benign and self-resolving, that it imitates cancer closely enough to justify biopsy, that a benign biopsy result is a good outcome rather than a wasted procedure, that surgery is usually avoided because it can cause more of the same problem, and that the expected course is gradual improvement all contribute to appropriate care and to less frustration with the assessment process.
Red flag symptoms include a lump that is enlarging rather than shrinking over time; a new lump in a different area of the breast; increasing skin dimpling, tethering, or thickening; new nipple retraction or discharge; redness and swelling that does not settle; a lump in the armpit; a new lump at the site of previous breast cancer treatment, which requires assessment to exclude recurrence; and any lump in a woman who has not had trauma, surgery, or radiotherapy at that site, in whom fat necrosis is a less likely explanation. These warrant prompt medical evaluation.